Section I
11 – 20 of 4941
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
FEASIBILITY AND POTENTIAL BENEFITS OF MODERATE INTENSITY CYCLING IN PEOPLE LIVING WITH LOWER LIMB LYMPHEDEMA : A PILOT RANDOMIZED CONTROLLED TRIAL
(
- Contribution to journal › Article
-
Mark
Assessing the feasibility of HPV screening for cervical cancer in pregnant women in Ethiopia
(
- Contribution to journal › Article
-
Mark
Lower MeDiC score is associated with non-referral to multidisciplinary team meeting discussion in bladder cancer patients : a nationwide and population-based study
(
- Contribution to journal › Article
-
Mark
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC : Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial
(
- Contribution to journal › Article
-
Mark
LUND-PROBE – LUND Prostate Radiotherapy Open Benchmarking and Evaluation dataset
(
- Contribution to journal › Article
-
Mark
Perioperative Risk Prediction in Head and Neck Free Flap Reconstructive Surgery
(
- Contribution to journal › Article
-
Mark
Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort
(
- Contribution to journal › Article
-
Mark
Swedish national guidelines on urothelial carcinoma : 2024 update on advanced and metastatic disease
(
- Contribution to journal › Article
-
Mark
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor : The AGITG ALT-GIST intergroup randomized phase II trial: Clinical Studies
(
- Contribution to journal › Article
-
Mark
Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung Cancer : A Target Trial Emulation Using Nationwide Swedish Registry Data
(
- Contribution to journal › Article